Explore

Healthy Living

News

Health A-Z

Calculators

Articles

Drugs

Directories

Education

More

Search Medindia

Medindia » Health Tips » New Discovery for Treatment and Prevention of Bone Tumors

New Discovery for Treatment and Prevention of Bone Tumors

One in every 50,000 people is affected with multiple hereditary exostoses (MHE). MHE is a rare genetic disease characterized by multiple bone tumors, affecting children during their growing years. Very limited treatment options and the age group that is affected emphasize the need to develop effective therapeutic strategies in treating the disease. A study conducted at the Sanford Burnham Prebys Medical Discovery Institute, USA, was successful in discovering the underlying mechanism of disease manifestation and also provide a potential therapy to treat MHE.

New Discovery for Treatment and Prevention of Bone Tumors

New Discovery for Treatment and Prevention of Bone Tumors

A small molecule BMP inhibitor may have therapeutic potential to treat and even prevent rare bone cancer, multiple hereditary exostoses (MHE).

Health Centers Specialty Health Quotes

Recommended Reading

Exostoses / Multiple Non-cancerous Bone Tumors - Causes, Symptoms, Diagnosis and Treatment

Exostoses / Multiple Non-cancerous Bone Tumors - Causes, Symptoms, Diagnosis and Treatment

Hereditary multiple exostoses is a genetic disorder that causes skeletal abnormalities. Read on about its causes and symptoms and also how this symptom can be diagnosed and treated.

Bone Marrow Cancer: New Insights into Boosting Tumor-Fighting Cells

Bone Marrow Cancer: New Insights into Boosting Tumor-Fighting Cells

Bone marrow cancer can be treated by using a new way that would boost the tumor-fighting cells.

Microwave Ablation Shows Promise in Relieving Painful Bone and Soft-Tissue Tumors

Microwave Ablation Shows Promise in Relieving Painful Bone and Soft-Tissue Tumors

Microwave ablation (MWA) therapy cut pain in half for patients with painful bone and soft-tissue tumors, new research has suggested.

In 90 Percent Of Most Common Childhood Bone Tumor, TP53-Tumor Suppressor Gene Mutated

In 90 Percent Of Most Common Childhood Bone Tumor, TP53-Tumor Suppressor Gene Mutated

The tumor suppressant gene TP53 has been found to be mutated in 90 percent of osteocarcomas, suggesting gene alteration plays a key role in early development of cancer, found by researchers.

Health Tips

More...

Health Tips - Specialty

More...

⬆️